Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-012124-85Phase 2Active
Phase 2, open-label trial of niacin in obesity (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Change in adipose tissue inflammation. Started Aug 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-012124-85.